At Pinpoint Radiotherapy,
we understand that starting cancer treatment can be overwhelming.
That’s why we’re dedicated to making your experience as smooth, comfortable, and supportive as possible.
Our patient-centred approach ensures that you’re cared for every step of the way, from the moment you walk through our doors to your final follow-up appointment.
The 4 steps of treatment
Make an Enquiry
Complete our make an enquiry form and one of our experienced team will contact you to discuss eligibility for our service and answer general questions you may have. Our goal is to ensure you are informed and confident in the care you will receive.
Developing a personalised treatment plan
If appropriate, you will then have a dedicated consultation appointment with Dr Bowden or Dr Conway, in person or via telehealth. You will discuss and receive a personalised treatment plan tailored to your specific needs. We’ll guide you through each step, ensuring you have all the information and support you need.
Treatment sessions
When it’s time to begin your treatment, you’ll be guided through every step. Our state-of-the-art Stereotactic Radiotherapy technology ensures that your treatment is both precise and comfortable.
Our caring staff will be with you throughout the session, ensuring you’re comfortable and addressing any concerns you may have.
Post-treatment care and
follow-up
After treatment, we’ll continue to support you with follow-up care and monitoring, ensuring you feel confident and addressing any concerns as they arise.
The Pinpoint Difference
Multiple treatment centres conveniently located across Melbourne and Canberra
Australian trained team
40+
Combined years
of clinical experience
Fast treatment
199 patients treated on the TRANSFORM trial - the world's largest clinical trial for stereotactic radiotherapy for oligometastatic prostate cancer
2000 cases in the past decade
The Pinpoint Difference
Multiple treatment centres conveniently located across Melbourne and Canberra
Fast treatment
199 patients treated on the TRANSFORM trial - the world's largest clinical trial for stereotactic radiotherapy for oligometastatic prostate cancer